CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sirtris Pharmaceuticals, Inc. (NASDAQ: SIRT), a biopharmaceutical company focused on discovering and developing small molecule drugs to treat diseases of aging such as Type 2 Diabetes, announced today that Peter Elliott, Ph.D, Senior Vice President of Development, will chair the 2nd Annual Metabolic Syndrome Forum and will present on October 17, 2007 at 1:45 pm EDT in Boston.
